Elevate CLL TN: Study of Obinutuzumab + Chlorambucil, Acalabrutinib (ACP-196) + Obinutuzumab, and Acalabrutinib in Subjects With Previously Untreated CLL
about
Elevate CLL TN: Study of Obinutuzumab + Chlorambucil, Acalabrutinib (ACP-196) + Obinutuzumab, and Acalabrutinib in Subjects With Previously Untreated CLL
description
clinical trial
@en
klinisch onderzoek
@nl
name
Elevate CLL TN: Study of Obinu ...... With Previously Untreated CLL
@en
Elevate CLL TN: Study of Obinu ...... With Previously Untreated CLL
@nl
type
label
Elevate CLL TN: Study of Obinu ...... With Previously Untreated CLL
@en
Elevate CLL TN: Study of Obinu ...... With Previously Untreated CLL
@nl
prefLabel
Elevate CLL TN: Study of Obinu ...... With Previously Untreated CLL
@en
Elevate CLL TN: Study of Obinu ...... With Previously Untreated CLL
@nl
P17
P1476
A Randomized, Multicenter, Ope ...... With Previously Untreated CLL
@en
P17
P3098
NCT02475681
P4844
P580
2015-06-01T00:00:00Z
P582
2019-12-01T00:00:00Z